• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[钙通道阻滞剂和心脏选择性β受体阻滞剂在嗜铬细胞瘤术前及术中管理中的单独应用。70例病例]

[Exclusive use of calcium channel blockers and cardioselective beta-blockers in the pre- and per-operative management of pheochromocytomas. 70 cases].

作者信息

Combemale F, Carnaille B, Tavernier B, Hautier M B, Thevenot A, Scherpereel P, Proye C

机构信息

Service de Chirurgie Générale et Endocrinienne, Hôpital Huriez, Centre Hospitalier Universitaiŕe de Lille.

出版信息

Ann Chir. 1998;52(4):341-5.

PMID:9752467
Abstract

The pre and intraoperative use of calcium channel blockers (CCB) has been suggested for the management of either eutopic or ectopic pheochromocytomas. We report our experience of 70 pheochromocytomas, operated between 1988 and 1996 and managed with CCB, especially nicardipine. 59 were hypertensive (84.2%). Preparation consisted of nicardipine in 61 patients or another CCB in 9 cases with duration ranging from 24 hours to several weeks depending on plasma volume and blood pressure control. Intraoperatively, nicardipine infusion was started after intubation, adjusted according to systolic blood pressure (SBP) and stopped before ligation of the tumor venous drainage. Increases in SBP greater than 200 mmHg were observed in 10 patients and were effectively controlled by nicardipine in all cases. In 16 patients, the S > BP remained less than 150 mmHg throughout anesthesia. Heart rate greater than 100 b p m occureed in 51 patients and was easily controlled with esmolol whenever used (n = 27). Arythmias were unfrequent (n = 4) and required treatment in only one case. This study confirms the ability to adequately manage pheochromocytomas with the use of nicardipine as sole vasodilating agent.

摘要

有人建议在术前和术中使用钙通道阻滞剂(CCB)来治疗原位或异位嗜铬细胞瘤。我们报告了1988年至1996年间手术治疗并使用CCB(尤其是尼卡地平)管理的70例嗜铬细胞瘤的经验。59例为高血压患者(84.2%)。61例患者的准备工作包括使用尼卡地平,9例使用其他CCB,持续时间从24小时到数周不等,具体取决于血容量和血压控制情况。术中,插管后开始输注尼卡地平,根据收缩压(SBP)进行调整,并在结扎肿瘤静脉引流前停止。10例患者观察到SBP升高超过200 mmHg,所有病例均通过尼卡地平有效控制。16例患者在整个麻醉过程中SBP均保持低于150 mmHg。51例患者心率超过100次/分钟,使用艾司洛尔时(n = 27)很容易得到控制。心律失常不常见(n = 4),仅1例需要治疗。本研究证实了使用尼卡地平作为唯一血管扩张剂充分管理嗜铬细胞瘤的能力。

相似文献

1
[Exclusive use of calcium channel blockers and cardioselective beta-blockers in the pre- and per-operative management of pheochromocytomas. 70 cases].[钙通道阻滞剂和心脏选择性β受体阻滞剂在嗜铬细胞瘤术前及术中管理中的单独应用。70例病例]
Ann Chir. 1998;52(4):341-5.
2
[Pre- and postoperative antihypertensive treatment with calcium antagonist in pheochromocytoma].[嗜铬细胞瘤患者术前及术后使用钙拮抗剂进行抗高血压治疗]
Arch Mal Coeur Vaiss. 1990 Jul;83(8):1123-5.
3
The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas.钙通道阻滞剂对嗜铬细胞瘤和副神经节瘤手术治疗后预后的影响。
Anaesthesia. 2005 May;60(5):439-44. doi: 10.1111/j.1365-2044.2005.04156.x.
4
Utility of oral nicardipine and magnesium sulfate infusion during preparation and resection of pheochromocytomas.口服尼卡地平与硫酸镁在嗜铬细胞瘤准备及切除术期间的应用。
Surgery. 2012 Dec;152(6):1027-36. doi: 10.1016/j.surg.2012.08.023.
5
Successful outcomes in pheochromocytoma surgery in the modern era.现代嗜铬细胞瘤手术的成功结果。
J Urol. 1999 Mar;161(3):764-7.
6
[Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension].[尼卡地平缓释片治疗轻/中度高血压的全国性药物监测项目]
Minerva Cardioangiol. 1995 Sep;43(9):399-408.
7
[Anesthetic management of undiagnosed pheochromocytoma: a case report].[未确诊嗜铬细胞瘤的麻醉管理:一例报告]
Masui. 2008 Oct;57(10):1241-4.
8
Both preoperative alpha and calcium channel blockade impact intraoperative hemodynamic stability similarly in the management of pheochromocytoma.在嗜铬细胞瘤的治疗中,术前使用α受体阻滞剂和钙通道阻滞剂对术中血流动力学稳定性的影响相似。
Surgery. 2014 Dec;156(6):1410-7; discussion1417-8. doi: 10.1016/j.surg.2014.08.022. Epub 2014 Nov 11.
9
Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.尼日利亚一家三级医院高血压药物治疗的趋势变化:对新旧抗高血压药物的疗效、安全性、合理性和药物经济学的真实世界评估
J Hum Hypertens. 2003 Apr;17(4):277-85. doi: 10.1038/sj.jhh.1001538.
10
Current status of antihypertensive prescription and associated blood pressure control in Japan.日本抗高血压药物处方现状及相关血压控制情况
Hypertens Res. 2006 Mar;29(3):143-51. doi: 10.1291/hypres.29.143.

引用本文的文献

1
Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients.嗜铬细胞瘤腹腔镜肾上腺切除术后并发症的预测因素:225例患者的多中心回顾性分析
Surg Endosc. 2016 Mar;30(3):1051-9. doi: 10.1007/s00464-015-4294-7. Epub 2015 Jun 20.
2
An interesting case of paraganglioma.一例有趣的副神经节瘤病例。
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.10.2008.1150. Epub 2009 May 25.
3
Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism.
高血压的肾上腺病因:嗜铬细胞瘤和原发性醛固酮增多症。
Rev Endocr Metab Disord. 2007 Dec;8(4):309-20. doi: 10.1007/s11154-007-9055-z.